Updated:
Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001656328, and its reported...
Overview
Sienna Biopharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001656328, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-14, it reported annual revenue of USD 0; net income of USD -73,471,000; total assets of USD 107,306,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Sienna Biopharmaceuticals, Inc.
- Former names in filing history
- Sienna Labs, Inc. (2015-10-20 to 2015-10-20)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Westlake Village, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001656328
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2018USD | $0 | -$73.5M | $107.3M | $48.5M | -$61.7M | |
| FY2017USD | — | -$50.5M | $136.8M | $74.5M | — |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Sienna Biopharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.